Literature DB >> 19307703

Functional characterization of the cAMP-binding proteins Epac in cardiac myocytes.

Mélanie Métrich1, Eric Morel, Magali Berthouze, Laetitia Pereira, Philippe Charron, Ana-Maria Gomez, Frank Lezoualc'h.   

Abstract

The cyclic AMP (cAMP)-binding proteins, Epac, are guanine nucleotide exchange factors for the Ras-like small GTPases. Since their discovery in 1998 and with the development of specific Epac agonists, many data in the literature have illustrated their critical role in multiple cellular events mediated by the second messenger cAMP. Given the importance of cAMP in cardiovascular physiology and physiopathology, there is a growing interest to delineate the role of these multi-domain Epac in the cardiovascular system. This review will focus on recent pharmacological and biochemical studies aiming at understanding the role of Epac in cardiomyocyte signaling and hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307703     DOI: 10.1016/s1734-1140(09)70017-9

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

1.  A CaMKII/PDE4D negative feedback regulates cAMP signaling.

Authors:  Delphine Mika; Wito Richter; Marco Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.

Authors:  Li Wang; Brian T Burmeister; Keven R Johnson; George S Baillie; Andrei V Karginov; Randal A Skidgel; John P O'Bryan; Graeme K Carnegie
Journal:  Cell Signal       Date:  2015-02-12       Impact factor: 4.315

3.  The inotropic peptide βARKct improves βAR responsiveness in normal and failing cardiomyocytes through G(βγ)-mediated L-type calcium current disinhibition.

Authors:  Mirko Völkers; Christian Weidenhammer; Oliver Friedrich; Patrick Most; Nicole Herzog; Gang Qiu; Kristin Spaich; Frederic V Wegner; Karsten Peppel; Oliver J Müller; Stefanie Schinkel; Joseph E Rabinowitz; Hans-Jorg Hippe; Henriette Brinks; Hugo A Katus; Walter J Koch; Andrea D Eckhart
Journal:  Circ Res       Date:  2010-11-24       Impact factor: 17.367

4.  cAMP inhibits modulation of airway smooth muscle phenotype via the exchange protein activated by cAMP (Epac) and protein kinase A.

Authors:  Sara S Roscioni; Bart G J Dekkers; Alwin G Prins; Mark H Menzen; Herman Meurs; Martina Schmidt; Harm Maarsingh
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 5.  Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology.

Authors:  Mélanie Métrich; Magali Berthouze; Eric Morel; Bertrand Crozatier; Ana Maria Gomez; Frank Lezoualc'h
Journal:  Pflugers Arch       Date:  2009-10-25       Impact factor: 3.657

6.  Calcium/calmodulin-dependent protein kinase II regulation of IKs during sustained β-adrenergic receptor stimulation.

Authors:  Tyler Shugg; Derrick E Johnson; Minghai Shao; Xianyin Lai; Frank Witzmann; Theodore R Cummins; Michael Rubart-Von-der Lohe; Andy Hudmon; Brian R Overholser
Journal:  Heart Rhythm       Date:  2018-02-02       Impact factor: 6.343

7.  β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.

Authors:  Yingxin Li; Fang Wang; Xiaoying Zhang; Zhao Qi; Mingxin Tang; Christopher Szeto; Ying Li; Hongyu Zhang; Xiongwen Chen
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

8.  The cAMP effector EPAC activates Elk1 transcription factor in prostate smooth muscle, and is a minor regulator of α1-adrenergic contraction.

Authors:  Martin Hennenberg; Frank Strittmatter; Henning Schmetkamp; Beata Rutz; Sebastian Walther; Christian G Stief; Christian Gratzke
Journal:  J Biomed Sci       Date:  2013-07-02       Impact factor: 8.410

9.  Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy.

Authors:  Wen-Xia Yang; Yu Liu; Shu-Min Zhang; Hua-Fen Wang; Yi-Fei Liu; Jia-Lu Liu; Xiao-Hui Li; Meng-Ru Zeng; Yu-Zhang Han; Fu-You Liu; Lin Sun; Li Xiao
Journal:  Acta Pharmacol Sin       Date:  2021-06-08       Impact factor: 6.150

10.  Suppression of Rap1 impairs cardiac myofibrils and conduction system in zebrafish.

Authors:  Wei Dong; Zhenglin Yang; Fan Yang; Jialiang Wang; Yan Zhuang; Chongren Xu; Bo Zhang; Xiao-Li Tian; Dong Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.